Skip to content

Navigation

  • Map
  • Episodes
  • Articles
  • Advertise
  • About Us
  • Subscribe Free

Social

YouTube Spotify Apple Podcasts
  • Map
  • Episodes
  • Articles
  • Advertise
  • About Us
Subscribe Free
background-splash
Philip Hemme

Philip Hemme

Founder of Flot.bio | Author | Founder of Labiotech.eu (exit) | Bioengineer

Claudia Ulbrich, Cardior 🇩🇪 | Being the Founder of a Rare €1B Exit | E15

Claudia Ulbrich, Cardior 🇩🇪 | Being the Founder of a Rare €1B Exit | E15

We’re in Hannover 🇩🇪 with the founder and CEO of Cardior, Claudia Ulbrich We talked...
Philip Hemme
Philip Hemme
• May 7, 2024
Bahija Jallal, Immunocore 🇬🇧 | Commercial, Diversity, and AI | E14

Bahija Jallal, Immunocore 🇬🇧 | Commercial, Diversity, and AI | E14

We’re super privileged to chat online with Bahija Jallal, the CEO of Immunocore. Immunocore is...
Philip Hemme
Philip Hemme
• Apr 4, 2024
Edwin Moses | How to build large biotech platforms | E13

Edwin Moses | How to build large biotech platforms | E13

We’re in Brussels with Edwin Moses, the former CEO of one of the most successful...
Philip Hemme
Philip Hemme
• Mar 7, 2024
Jens Nielsen, BII | How to make translation of life science research work | E12

Jens Nielsen, BII | How to make translation of life science research work | E12

We’re in Copenhagen with Jens Nielsen, the CEO of BioInnovation Institute. We will talk about...
Philip Hemme
Philip Hemme
• Feb 5, 2024
Sander van Deventer, VectorY & Forbion | Pioneering gene therapy | E11

Sander van Deventer, VectorY & Forbion | Pioneering gene therapy | E11

We’re in Amsterdam with Sander van Deventer, the CEO of VectorY. We will talk about...
Philip Hemme
Philip Hemme
Forbiongene therapy
• Jan 15, 2024
Thomas Clozel, Owkin | What does AI Biotech really mean | E10

Thomas Clozel, Owkin | What does AI Biotech really mean | E10

In an online special, we’re interviewing Thomas Clozal, the co-founder and CEO of Owkin. We...
Philip Hemme
Philip Hemme
• Dec 18, 2023
Marc de Garidel, Abivax | How to make two Billion-dollar exits (“smoothly”) | E09

Marc de Garidel, Abivax | How to make two Billion-dollar exits (“smoothly”) | E09

Today, I’m in Paris to chat with Marc de Garidel, the new CEO of Abivax....
Philip Hemme
Philip Hemme
• Dec 4, 2023
Mike Ward | The Best and the Worst since the 80s in EU Biotech | E08

Mike Ward | The Best and the Worst since the 80s in EU Biotech | E08

Today we’re in Munich at BIO-Europe to chat with one of the best commentators in...
Philip Hemme
Philip Hemme
• Nov 20, 2023
Agnete Fredriksen, Nykode | Being one of the top 50 women in 🇪🇺 bio | E07

Agnete Fredriksen, Nykode | Being one of the top 50 women in 🇪🇺 bio | E07

We’re live from Oslo 🇳🇴 to catch up with Agnete Fredriksen, co-founder and CBO of Nykode...
Philip Hemme
Philip Hemme
• Oct 31, 2023
Rodger Novak, CRISPR Tx | #1 CRISPR Drug | E06

Rodger Novak, CRISPR Tx | #1 CRISPR Drug | E06

Biotech great Rodger Novak, Co-Founder and Chairman of CRISPR Tx joins us on the show....
Philip Hemme
Philip Hemme
• Sep 21, 2023

« 1 … 6 7 8 9 »

Never Miss a New Episode 💌

Trusted by 2500+ biopharma professionals from top companies like argenx, Roche, and Forbion. No spam, no noise.

Newsletter preferences

Please select at least one option to subscribe.

By subscribing you agree to our privacy policy.

Watch & Subscribe

Flot.bio on Youtube Flot.bio on Spotify Flot.bio on Apple Podcasts
Flot.bio
  • Map
  • Episodes
  • Articles
  • About Us
  • Donate
  • Media Kit
  • Subscribe Free

Contact us via Katherine: hi@flot.bio

Follow Us:

Latest Episode:
Red Hot Rare Diseases and Europe’s record funding with Regina Hodits, Angelini Ventures | E63
Latest Article:
Top 35 Biotech Startups to Watch in Europe
Flot.bio © 2026
Made with ❤ in Europe 🇪🇺
  • Imprint
  • Privacy Policy